[Las Vegas (USA) = AVING News] HM Square Co., Ltd. (CEO Kang Yoon-ho), a company developing continuous blood glucose meters, held a conference in Las Vegas, USA for a total of 1 days from January 5th (Thursday) to 8th (Sunday, local time). Participated in the open ‘CES 4’.
HM Square, an incubator company of the Gyeonggi Creative Economy Innovation Center, was established in 2020 and is a company that strives to contribute to the development of a sustainable human community. The company name was ‘HME’, which is derived from the first letters of the company’s mission ‘Honor’, ‘Mankind’, and ‘Earth’ and vision ‘Health’, ‘Mobility’, and ‘Energy’, with the aim of helping humanity live a healthy life. We are developing products and services.
‘Glucosound’, developed by HM Square, is a glucose monitoring system that does not require blood sample collection or needles. We worked to improve the lives of diabetic patients by emphasizing non-invasive blood sugar check based on MEMS sensor technology. It also received an innovation award in the digital health category at CES 2023.
Kang Yun-ho, CEO of HM Square, said, “There have been consistent requests from diabetes-related patients and medical staff. “There were similar products, but they were not approved by the FDA due to differences in accuracy values,” he said. “We expected that our product would be able to receive FDA approval by recording an error rate of less than 10%, and we held a demonstration on site and received attention from booth visitors.” “He said.
GlucoSound is a biotech product developed with semiconductor technology and aims to measure blood sugar in a wearable form. The company explained that in the future, it will expand to measure other biological substances in the body.
CEO Kang said, “Our goal is to measure biological substances such as cholesterol, creatinine, and bilirubin. We can measure the blood in the blood vessels without collecting any blood at all.” Since it is a non-invasive product, it is measured using ultrasonic waves generated by shooting light with a laser. So, the advantage is that the patient does not experience any pain or discomfort.”
He continued, “Using this CES as a stepping stone, we plan to enter developing countries suffering from diabetes complications, including the United States, which accounts for 40% of the diabetes-related medical market,” and added, “Our product is a wearable personal device. Currently, most wearable medical devices are expensive products and have limited medical insurance coverage. Accordingly, we plan to produce and commercialize low-cost portable products along with wearable products,” he said.
Meanwhile, ‘CES’, the world’s largest IT exhibition, is an exhibition where you can understand the trends of the global home appliance industry at a glance. Hosted by the Consumer Technology Association (CTA), it is held every January in Las Vegas, USA. AVING News, which has covered CES for 1 consecutive years, has reported CES news around the world every year since 17, and has been selected as the ‘BEST OF CES’, which selects the best innovative products and technologies, and the ‘BEST OF’, which selects domestic innovative companies. ‘MADE IN KOREA’ was held. In addition, CES on-site issues were vividly conveyed through ‘AVING LIVE’.
→ Go to the CES 2023 news special page
→ Apply for ‘CES2023 Global Review & Conference in Seoul’ once
→ Apply for the second ‘CES2023 Global Review & Conference in Seoul’
